- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Cancer Immunology, Immunotherapy 71.6 (2022): S. 1467-1477.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2022
- Urheber
-
Koch, Elias A. T.
Petzold, Anne
Wessely, Anja
Dippel, Edgar
Erdmann, Michael
Heinzerling, Lucie
Hohberger, Bettina
Knorr, Harald
Leiter, Ulrike
Meier, Friedegund
Mohr, Peter
Rahimi, Farnaz
Schell, Beatrice
Schlaak, Max
Terheyden, Patrick
Schuler-Thurner, Beatrice
Ugurel, Selma
Utikal, Jochen
Vera, Julio
Weichenthal, Michael
Ziller, Fabian
Berking, Carola
Heppt, Markus V.
- DOI
-
10.1007/s00262-021-03090-4
- URN
-
urn:nbn:de:bvb:29-opus4-220939
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:51 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koch, Elias A. T.
- Petzold, Anne
- Wessely, Anja
- Dippel, Edgar
- Erdmann, Michael
- Heinzerling, Lucie
- Hohberger, Bettina
- Knorr, Harald
- Leiter, Ulrike
- Meier, Friedegund
- Mohr, Peter
- Rahimi, Farnaz
- Schell, Beatrice
- Schlaak, Max
- Terheyden, Patrick
- Schuler-Thurner, Beatrice
- Ugurel, Selma
- Utikal, Jochen
- Vera, Julio
- Weichenthal, Michael
- Ziller, Fabian
- Berking, Carola
- Heppt, Markus V.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2022
Ähnliche Objekte (12)
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Determinants of survival in patients with brain metastases from cutaneous melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV)
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Langzeitpositive - Aspekte des Longterm Survival
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Persistent painless hemospermia due to metastatic melanoma of the right seminal vesicle
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Determinants of survival in patients with brain metastases from cutaneous melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV)
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Langzeitpositive - Aspekte des Longterm Survival
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Persistent painless hemospermia due to metastatic melanoma of the right seminal vesicle
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma
Systemic treatment of metastatic uveal melanoma: review of literature and future perspectives
Functional immunological parameters associated with long-term survival of patients with metastatic melanoma
Determinants of survival in patients with brain metastases from cutaneous melanoma
Primary Resistance to Immune Checkpoint Inhibitors in Patients with Metastatic Melanoma : Prognosis, Subsequent Therapies and Survival
Long-Term Relapse-Free Survival by Interdisciplinary Collaboration in a Patient with Metastatic Pancreatic Cancer (UICC IV)
Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
Immune checkpoint blockade for metastatic uveal melanoma: patterns of response and survival according to the presence of hepatic and extrahepatic metastasis
Langzeitpositive - Aspekte des Longterm Survival
Predicting response to immunotherapy in metastatic melanoma by a personalized mathematical model
Persistent painless hemospermia due to metastatic melanoma of the right seminal vesicle
Efficacy and safety of ripretinib in patients with KIT-altered metastatic melanoma